Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.
Clinical trial NCT02945852 · COMPLETED
Trial details
- NCT number
- NCT02945852
- Sponsor
- Fan Yun, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-11-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.